NiceRx
Editorial reviewA medication-access veteran turned GLP-1 provider — LegitScript-verified and nationwide, if middle-priced.
Visit NiceRxHead-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
A medication-access veteran turned GLP-1 provider — LegitScript-verified and nationwide, if middle-priced.
Visit NiceRxA coaching-first program with aggressive, identical pricing on both molecules.
Visit FoundFound takes it with a higher Verdict Score — 88/100 to 85/100 (grade B+ vs B). People who want behavior-change coaching bundled with medication. NiceRx still earns its place — patients who want an established, verified name over the cheapest newcomer.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | NiceRx | Found |
|---|---|---|
| Verdict Score | 85/100 | 88/100 |
| Grade | B | B+ |
| Semaglutide | $199/mo | $129/mo |
| Tirzepatide | $299/mo | $129/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
| Relationship | Editorial | Editorial |
What we like
The caveats
What we like
The caveats
Also worth a look
Patients who want an established, verified name over the cheapest newcomer.
Visit NiceRx Read the full NiceRx review →Our pick — visit
People who want behavior-change coaching bundled with medication.
Visit Found Read the full Found review →Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.